 SOUTH PLAINFIELD, N.J., Feb. 26, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT, today announced that the European Medicines Agency EMA Committee for Medicinal Products for Human Use CHMP has recommended the approval of EvrysdiTM risdiplam for the treatment of 5q spinal... 